Banking on stem cells
Last month, the British Medical Research Council announced at a stem cell conference in London that it will go ahead with the launch of a national bank to hold adult and embryonic stem cell lines. The call for such a repository had been initiated by the Royal Society over two years ago and it was endorsed in a report from the House of Lords select committee on stem cell research earlier this year. The National Institute of Biological standards and control (NIBSC) will be responsible for this task, for which it has been awarded £2.6 million. A steering committee with a broad representation of various interest groups is currently being put in place to oversee the activities of the bank and to regulate the use of embryonic stem (ES) cell lines. If the broad input from different interest groups cultivated at the conference is anything to go by, critics need not worry about getting a fair say.
This represents the first such depository of its kind and we applaud this move: a core facility governing the distribution and use of stem cells is the best way to ensure the distribution of ethically approved, quality controlled stem cells. Meanwhile, in the US the National Institutes of Health has managed to keep the doors open to ES cell research in its labs by backing a more liberal interpretation of President Bush's 2001 stem cell announcement. The UK bank will be tightly regulated and controlled, establishing standards for the ethical derivation and use of human ES cells that will hopefully spread past its national borders. This resource will ensure that the UK continues to play a central role in the promotion of stem cell research.
